Corrigendum to “Refinement of imidazo[2,1-a]pyrimidines in pursuit of potential drug candidates against group 2 influenza A viruses” [Europ. J. Med. Chem. 2925 (2025) 117679] (European Journal of Medicinal Chemistry (2025) 292, (S0223523425004441), (10.1016/j.ejmech.2025.117679))

Malaika D. Argade; Varada Anirudhan; Sean P. Bradley; Łukasz Tomorowicz; Ryan Bott; Boopathi Sownthirarajan; Christian A. Zielinski; John P. Sloan; Dejan S. Nikolic; Arsen M. Gaisin; Terry W. Moore; Balaji Manicassamy; Norton P. Peet; Lijun Rong; Irina N. Gaisina

doi:10.1016/j.ejmech.2025.117766

Corrigendum to “Refinement of imidazo[2,1-a]pyrimidines in pursuit of potential drug candidates against group 2 influenza A viruses” [Europ. J. Med. Chem. 2925 (2025) 117679] (European Journal of Medicinal Chemistry (2025) 292, (S0223523425004441), (10.1016/j.ejmech.2025.117679))

Malaika D. Argade
, Varada Anirudhan
, Sean P. Bradley
, Łukasz Tomorowicz
, Ryan Bott
, Boopathi Sownthirarajan
, Christian A. Zielinski
, John P. Sloan
, Dejan S. Nikolic
, Arsen M. Gaisin
, Terry W. Moore
, Balaji Manicassamy
, Norton P. Peet
, Lijun Rong
, Irina N. Gaisina

Research output: Contribution to journal › Comment/debate

Abstract

The authors regret that the post-publication review showed the presence of “ = ” signs before and in some cases after the text in Tables. 1 and 2 (column 3) pasted incorrectly, which was caused by the mismatch of file versions during the revision process. Corrected Tables. 1 and 2 are shown below. [Table presented] [Table presented] These modifications did not impact any experimental conclusions and there is no need to change the original text. The authors would like to apologise for any inconvenience caused.

Original language	English
Article number	117766
Journal	European Journal of Medicinal Chemistry
Volume	294
DOIs	https://doi.org/10.1016/j.ejmech.2025.117766
State	Published - 15 Sep 2025
Externally published	Yes

Access to Document

10.1016/j.ejmech.2025.117766

Fingerprint

Dive into the research topics of 'Corrigendum to “Refinement of imidazo[2,1-a]pyrimidines in pursuit of potential drug candidates against group 2 influenza A viruses” [Europ. J. Med. Chem. 2925 (2025) 117679] (European Journal of Medicinal Chemistry (2025) 292, (S0223523425004441), (10.1016/j.ejmech.2025.117679))'. Together they form a unique fingerprint.

Cite this

Argade, M. D., Anirudhan, V., Bradley, S. P., Tomorowicz, Ł., Bott, R., Sownthirarajan, B., Zielinski, C. A., Sloan, J. P., Nikolic, D. S., Gaisin, A. M., Moore, T. W., Manicassamy, B., Peet, N. P., Rong, L., & Gaisina, I. N. (2025). Corrigendum to “Refinement of imidazo[2,1-a]pyrimidines in pursuit of potential drug candidates against group 2 influenza A viruses” [Europ. J. Med. Chem. 2925 (2025) 117679] (European Journal of Medicinal Chemistry (2025) 292, (S0223523425004441), (10.1016/j.ejmech.2025.117679)). European Journal of Medicinal Chemistry, 294, Article 117766. https://doi.org/10.1016/j.ejmech.2025.117766

Argade, Malaika D. ; Anirudhan, Varada ; Bradley, Sean P. et al. / Corrigendum to “Refinement of imidazo[2,1-a]pyrimidines in pursuit of potential drug candidates against group 2 influenza A viruses” [Europ. J. Med. Chem. 2925 (2025) 117679] (European Journal of Medicinal Chemistry (2025) 292, (S0223523425004441), (10.1016/j.ejmech.2025.117679)). In: European Journal of Medicinal Chemistry. 2025 ; Vol. 294.

@article{8139cfc3c0674c21b998eb21809aab69,

title = "Corrigendum to “Refinement of imidazo[2,1-a]pyrimidines in pursuit of potential drug candidates against group 2 influenza A viruses” [Europ. J. Med. Chem. 2925 (2025) 117679] (European Journal of Medicinal Chemistry (2025) 292, (S0223523425004441), (10.1016/j.ejmech.2025.117679))",

abstract = "The authors regret that the post-publication review showed the presence of “ = ” signs before and in some cases after the text in Tables. 1 and 2 (column 3) pasted incorrectly, which was caused by the mismatch of file versions during the revision process. Corrected Tables. 1 and 2 are shown below. [Table presented] [Table presented] These modifications did not impact any experimental conclusions and there is no need to change the original text. The authors would like to apologise for any inconvenience caused.",

author = "Argade, \{Malaika D.\} and Varada Anirudhan and Bradley, \{Sean P.\} and {\L}ukasz Tomorowicz and Ryan Bott and Boopathi Sownthirarajan and Zielinski, \{Christian A.\} and Sloan, \{John P.\} and Nikolic, \{Dejan S.\} and Gaisin, \{Arsen M.\} and Moore, \{Terry W.\} and Balaji Manicassamy and Peet, \{Norton P.\} and Lijun Rong and Gaisina, \{Irina N.\}",

note = "Publisher Copyright: {\textcopyright} 2025 Elsevier Masson SAS",

year = "2025",

month = sep,

day = "15",

doi = "10.1016/j.ejmech.2025.117766",

language = "English",

volume = "294",

journal = "European Journal of Medicinal Chemistry",

issn = "0223-5234",

publisher = "Elsevier Masson s.r.l.",

}

Argade, MD, Anirudhan, V, Bradley, SP, Tomorowicz, Ł, Bott, R, Sownthirarajan, B, Zielinski, CA, Sloan, JP, Nikolic, DS, Gaisin, AM, Moore, TW, Manicassamy, B, Peet, NP, Rong, L & Gaisina, IN 2025, 'Corrigendum to “Refinement of imidazo[2,1-a]pyrimidines in pursuit of potential drug candidates against group 2 influenza A viruses” [Europ. J. Med. Chem. 2925 (2025) 117679] (European Journal of Medicinal Chemistry (2025) 292, (S0223523425004441), (10.1016/j.ejmech.2025.117679))', European Journal of Medicinal Chemistry, vol. 294, 117766. https://doi.org/10.1016/j.ejmech.2025.117766

Corrigendum to “Refinement of imidazo[2,1-a]pyrimidines in pursuit of potential drug candidates against group 2 influenza A viruses” [Europ. J. Med. Chem. 2925 (2025) 117679] (European Journal of Medicinal Chemistry (2025) 292, (S0223523425004441), (10.1016/j.ejmech.2025.117679)). / Argade, Malaika D.; Anirudhan, Varada; Bradley, Sean P. et al.
In: European Journal of Medicinal Chemistry, Vol. 294, 117766, 15.09.2025.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum to “Refinement of imidazo[2,1-a]pyrimidines in pursuit of potential drug candidates against group 2 influenza A viruses” [Europ. J. Med. Chem. 2925 (2025) 117679] (European Journal of Medicinal Chemistry (2025) 292, (S0223523425004441), (10.1016/j.ejmech.2025.117679))

AU - Argade, Malaika D.

AU - Anirudhan, Varada

AU - Bradley, Sean P.

AU - Tomorowicz, Łukasz

AU - Bott, Ryan

AU - Sownthirarajan, Boopathi

AU - Zielinski, Christian A.

AU - Sloan, John P.

AU - Nikolic, Dejan S.

AU - Gaisin, Arsen M.

AU - Moore, Terry W.

AU - Manicassamy, Balaji

AU - Peet, Norton P.

AU - Rong, Lijun

AU - Gaisina, Irina N.

PY - 2025/9/15

Y1 - 2025/9/15

N2 - The authors regret that the post-publication review showed the presence of “ = ” signs before and in some cases after the text in Tables. 1 and 2 (column 3) pasted incorrectly, which was caused by the mismatch of file versions during the revision process. Corrected Tables. 1 and 2 are shown below. [Table presented] [Table presented] These modifications did not impact any experimental conclusions and there is no need to change the original text. The authors would like to apologise for any inconvenience caused.

AB - The authors regret that the post-publication review showed the presence of “ = ” signs before and in some cases after the text in Tables. 1 and 2 (column 3) pasted incorrectly, which was caused by the mismatch of file versions during the revision process. Corrected Tables. 1 and 2 are shown below. [Table presented] [Table presented] These modifications did not impact any experimental conclusions and there is no need to change the original text. The authors would like to apologise for any inconvenience caused.

UR - https://www.scopus.com/pages/publications/105005649274

U2 - 10.1016/j.ejmech.2025.117766

DO - 10.1016/j.ejmech.2025.117766

M3 - Comment/debate

AN - SCOPUS:105005649274

SN - 0223-5234

VL - 294

JO - European Journal of Medicinal Chemistry

JF - European Journal of Medicinal Chemistry

M1 - 117766

ER -

Argade MD, Anirudhan V, Bradley SP, Tomorowicz Ł, Bott R, Sownthirarajan B et al. Corrigendum to “Refinement of imidazo[2,1-a]pyrimidines in pursuit of potential drug candidates against group 2 influenza A viruses” [Europ. J. Med. Chem. 2925 (2025) 117679] (European Journal of Medicinal Chemistry (2025) 292, (S0223523425004441), (10.1016/j.ejmech.2025.117679)). European Journal of Medicinal Chemistry. 2025 Sep 15;294:117766. doi: 10.1016/j.ejmech.2025.117766